The Coalition for Epidemic Preparedness and Innovation (CEPI) will fast-track three promising vaccines under development, and has called for proposals for additional vaccine candidates.
Read more https://t.co/81AWjjQgke
An experimental vaccine for the Bundibugyo Ebola virus is under development by the same group which produced one of the first COVID-19 vaccines.
The @OxfordVacGroup says the jab could begin human trials in two or three months.
Read more
https://t.co/u9icefNiC5
Disease outbreaks should be the top concern for AI developers in global health, according to the first ever priority-setting report.
That was the view of low- and middle-income country experts - those in rich countries thought differently.
Read more https://t.co/4bkJIWD71m
AI firms @Anthropic and @OpenAI have both agreed deals with the Gates Foundation to increase the use of AI in global health.
Read more https://t.co/XZhiOT2Lt2
Vaccine group @gavi bolsters African vaccine fund.
The vaccine alliance will ask its board to approve $198 million in spending, building on $1.2 billion set aside in 2024. up to 70 million vaccine doses from African manufacturers.
Read more https://t.co/fVNQl9EIIp
Subscribe to our free fortnighly news alert focusing on AI in global health.
Each edition includes the latest news updates, our policy roundup, new funding calls, and examples of successful implementation of AI in global health.
https://t.co/LurRSPAEsj
Innocent victims.
Israeli forces have killed over 60 children in the occupied West Bank since the start of last year �� most of them by live ammunition, according to a statement by the UN children’s agency @UNICEF .
Read more https://t.co/8CBM0mNfHd
Disease outbreaks should be the top concern for AI developers in global health, according to the first ever priority-setting report.
That was the view of low- and middle-income country experts - those in rich countries thought differently.
Read more https://t.co/4bkJIWD71m
"This is a defining moment" - Dr. Jean Kaseya, Director General, @AfricaCDC CDC
South African vaccine-maker Biovac has secured a $20 million loan to make vaccines for diseases such as polio, meningitis, pneumonia and cholera.
Read more https://t.co/lgdVPho4jo
CPHIA is vitally important as the continent works to build its ability to make vaccines and drugs. It's the best way to make sure that the vaccine inequity that emerged during the COVID 19 pandemic will never happen again.
Read more https://t.co/fagQHHrAov
Disease outbreaks should be the top concern for AI developers in global health, according to the first ever priority-setting report.
That was the view of low- and middle-income country experts - those in rich countries thought differently.
Read more https://t.co/4bkJIWD71m
Join us this Thursday for an important briefing on the Africa Health Security and Sovereignty (AHSS) agenda, including the latest on health emergencies across the continent.
From preparedness and response to stronger coordination and African-led solutions, the session will spotlight priorities for building more resilient health systems.
📅 Date: Thursday, 07 May 2026
🕓 Time:
* 16:00 | EAT (GMT+3)
* 15:00 | SAST (GMT+2)
* 14:00 | CAT (GMT+1)
* 13:00 | WAT (GMT)
🔗 Register to participate: https://t.co/sJ7wtqMn8d
#HealthSecurity
Subscribe to our free fortnighly news alert focusing on AI in global health.
Each edition includes the latest news updates, our policy roundup, new funding calls, and examples of successful implementation of AI in global health.
https://t.co/LurRSPAEsj
It comes after it announced in March that Pfizer, which holds an around 5 per cent stake, would go ahead and seek regulatory approval for their joint Lyme disease vaccine, even though one of the trial criteria was not met due to fewer-than-anticipated cases of the disease.
Vaccine specialist Valneva has sold new shares worth €84 million as it moves to strengthen its balance sheet in the wake of mixed results for its Lyme disease vaccine in a large-scale trial.
Read more https://t.co/T539CUcRyW
The world's smallest malaria patients now have a treatment made especially for them - thanks to the work of Lutz Hegemann and the team at @Novartis
Read more - https://t.co/vjsNJQKsKB